Author

Marisol Cisternas-Olmedo

Universidad MayorORCID 0000-0001-9610-9454Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

René L. VidaliD· 3 shared Alberto J. M. MartíniD· 2 shared Claudio A. HetziD· 2 shared Lars PlateiD· 2 shared Paula García-Huerta· 2 shared Paulina Troncoso-EscuderoiD· 2 shared R. Luke WisemaniD· 2 shared S. Pablo SardiiD· 2 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersNeuroscience

René L. VidalORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

GenomicsInternational Journal of Molecular SciencesPeer-reviewedJun 29, 2023

Transcriptional and Histone acetylation changes associated with CRE elements expose key factors governing the regulatory circuit in early stage of Huntington's disease models.

Sandra Arancibia-Opazo, Sebastián Contreras-Riquelme, Mario Sánchez…·Mauricio Sáez

10 citations

mousebulk RNA-seq

𝕏 PostBluesky

NeuroscienceMolecular TherapyPeer-reviewedFeb 5, 2021

Enforced dimerization between XBP1s and ATF6f enhances the protective effects of the unfolded protein response (UPR) in models of neurodegeneration

René L. Vidal, Denisse Sepúlveda, Paulina Troncoso-Escudero…·Claudio A. Hetz

This study shows that forcing dimerization between ATF6f and XBP1s enhances UPR activity, reducing protein aggregation in neurodegenerative disease models.

42 citations

𝕏 PostBluesky

NeuroscienceActa NeuropathologicaPeer-reviewedJul 8, 2020

Insulin-like growth factor 2 (IGF2) protects against Huntington's disease through the extracellular disposal of protein aggregates

Paula García-Huerta, Paulina Troncoso-Escudero, Di Wu…·Claudio A. Hetz

This study identifies IGF2 as a disease modifier that reduces intracellular protein aggregates by promoting their extracellular disposal in Huntington's disease models.

70 citationstop 3%

𝕏 PostBluesky